164 related articles for article (PubMed ID: 11684842)
1. MRI appearance of prostate following transrectal HIFU ablation of localized cancer.
Rouvière O; Lyonnet D; Raudrant A; Colin-Pangaud C; Chapelon JY; Bouvier R; Dubernard JM; Gelet A
Eur Urol; 2001 Sep; 40(3):265-74. PubMed ID: 11684842
[TBL] [Abstract][Full Text] [Related]
2. MR imaging of prostate after treatment with high-intensity focused ultrasound.
Kirkham AP; Emberton M; Hoh IM; Illing RO; Freeman AA; Allen C
Radiology; 2008 Mar; 246(3):833-44. PubMed ID: 18223121
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced US.
Rouvière O; Glas L; Girouin N; Mège-Lechevallier F; Gelet A; Dantony E; Rabilloud M; Chapelon JY; Lyonnet D
Radiology; 2011 May; 259(2):583-91. PubMed ID: 21357522
[TBL] [Abstract][Full Text] [Related]
4. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
5. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.
Sedelaar JP; Aarnink RG; van Leenders GJ; Beerlage HP; Debruyne FM; Wijkstra H; de La Rosette JJ
Eur Urol; 2000 May; 37(5):559-68. PubMed ID: 10765094
[TBL] [Abstract][Full Text] [Related]
6. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
[TBL] [Abstract][Full Text] [Related]
7. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
Kim CK; Park BK; Lee HM; Kim SS; Kim E
AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
[TBL] [Abstract][Full Text] [Related]
8. Local control of prostate cancer by transrectal HIFU-therapy.
Kiel HJ; Wieland WF; Rössler W
Arch Ital Urol Androl; 2000 Dec; 72(4):313-9. PubMed ID: 11221062
[TBL] [Abstract][Full Text] [Related]
9. High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment-a 5-year experience.
Collins K; Brocken E; Bahler CD; Alabd A; Koch MO; Cheng L
Hum Pathol; 2022 Jan; 119():79-84. PubMed ID: 34801600
[TBL] [Abstract][Full Text] [Related]
10. Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications.
Vellet AD; Saliken J; Donnelly B; Raber E; McLaughlin RF; Wiseman D; Ali-Ridha NH
Radiology; 1997 Jun; 203(3):653-9. PubMed ID: 9169684
[TBL] [Abstract][Full Text] [Related]
11. MRI evaluation following partial HIFU therapy for localized prostate cancer: A single-center study.
Hoquetis L; Malavaud B; Game X; Beauval JB; Portalez D; Soulie M; Rischmann P
Prog Urol; 2016 Sep; 26(9):517-23. PubMed ID: 27567745
[TBL] [Abstract][Full Text] [Related]
12. Effect of high-intensity focused ultrasound on human prostate cancer in vivo.
Madersbacher S; Pedevilla M; Vingers L; Susani M; Marberger M
Cancer Res; 1995 Aug; 55(15):3346-51. PubMed ID: 7542168
[TBL] [Abstract][Full Text] [Related]
13. Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application.
Madersbacher S; Kratzik C; Marberger M
Ultrason Sonochem; 1997 Apr; 4(2):175-9. PubMed ID: 11237038
[TBL] [Abstract][Full Text] [Related]
14. Prostate swelling and shift during high intensity focused ultrasound: implication for targeted focal therapy.
Shoji S; Uchida T; Nakamoto M; Kim H; de Castro Abreu AL; Leslie S; Sato Y; Gill IS; Ukimura O
J Urol; 2013 Oct; 190(4):1224-32. PubMed ID: 23583532
[TBL] [Abstract][Full Text] [Related]
15. High-intensity focused ultrasound (HIFU) hemiablation of the prostate: Late follow-up MRI findings in non-recurrent patients.
Schaudinn A; Michaelis J; Franz T; Ho-Thi P; Horn LC; Blana A; Hadaschik B; Stumpp P; Stolzenburg JU; Schlemmer HP; Denecke T; Busse H; Ganzer R; Linder N
Eur J Radiol; 2021 Nov; 144():109957. PubMed ID: 34601322
[TBL] [Abstract][Full Text] [Related]
16. Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI.
Curiel L; Souchon R; Rouvière O; Gelet A; Chapelon JY
Ultrasound Med Biol; 2005 Nov; 31(11):1461-8. PubMed ID: 16286025
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of color Doppler in guiding prostate biopsy after HIFU ablation.
Rouvière O; Mège-Lechevallier F; Chapelon JY; Gelet A; Bouvier R; Boutitie F; Lyonnet D
Eur Urol; 2006 Sep; 50(3):490-7. PubMed ID: 16439055
[TBL] [Abstract][Full Text] [Related]
18. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
Inoue Y; Goto K; Hayashi T; Hayashi M
Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
[TBL] [Abstract][Full Text] [Related]
19. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
Silverman JM; Krebs TL
AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
[TBL] [Abstract][Full Text] [Related]
20. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
